Adhesive small bowel obstruction: where do we stand now?

Authors

  • Barbara Leone School of Medicine, University “G.d’Annunzio” Chieti – Pescara, via dei Vestini n. 100, 66100 Chieti, Italy|Department of General and Thoracic Surgery, University Hospital of Chieti, via dei Vestini n. 1, 66100 Chieti, Italy
  • Decio Di Nuzzo Department of General and Thoracic Surgery, University Hospital of Chieti, via dei Vestini n. 1, 66100 Chieti, Italy
  • Felice Mucilli Department of General and Thoracic Surgery, University Hospital of Chieti, via dei Vestini n. 1, 66100 Chieti, Italy
  • Giuseppe Cipollone Department of General and Thoracic Surgery, University Hospital of Chieti, via dei Vestini n. 1, 66100 Chieti, Italy
  • Massimo Ippoliti Department of General and Thoracic Surgery, University Hospital of Chieti, via dei Vestini n. 1, 66100 Chieti, Italy
  • Mirko Barone Department of General and Thoracic Surgery, University Hospital of Chieti, via dei Vestini n. 1, 66100 Chieti, Italy
Abstract:

Adhesive small bowel obstruction (ASBO) is one of the most frequently encountered disorders in Emergency Surgery Departments worldwide without negligible hospital admission rates and social costs (1,2). Notwithstanding significant improvements in techniques and materials, intra-abdominal adhesions following abdominal surgery still represent a major unsolved and debated issue harbouring challenges regarding diagnosis, pathogenesis, management and  revention. In this setting, the cornerstone lies on a proper nosological classification with a subsequent diagnostic dilemma in distinguishing ASBO from other causes of obstruction and in an early identification of emergency surgery cases. conflicting results raise more questions.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

The Battle Against COVID-19: Where Do We Stand Now?

full text

Angiogenesis: where do we stand now?

Angiogenesis : Where Do We Stand Now? Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2005 American Heart Association, Inc. All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Circulation doi: 10.1161/01.CIR.0000159345.00591.8F 2005;111:1556-1566 Circulation. http://circ.ahajournals.org/content/111/12/1556 World Wide Web at: Th...

full text

Biliary atresia: Where do we stand now?

The pathway from clinical suspicion to establishing the diagnosis of biliary atresia in a child with jaundice is a daunting task. However, investigations available help to point towards the correct diagnosis in reasonable time frame. Imaging by Sonography has identified several parameters which can be of utility in the diagnostic work up. Comparison of Sonography with imaging by Nuclear medicin...

full text

Clinical Pharmacy in Iran: Where Do We Stand?

Since late 1960s, pharmacists in the USA and England have started a professional movement towards a more efficient presence in clinical wards of hospitals. A similar movement has started in developed European countries during the past decade. Pharmacists are convinced of the need for them to play their role as drug consultants and pharmacotherapy advisers to make decisions on drug therapy probl...

full text

Clinical Pharmacy in Iran: Where Do We Stand?

Since late 1960s, pharmacists in the USA and England have started a professional movement towards a more efficient presence in clinical wards of hospitals. A similar movement has started in developed European countries during the past decade. Pharmacists are convinced of the need for them to play their role as drug consultants and pharmacotherapy advisers to make decisions on drug therapy probl...

full text

Biologics in vasculitides: Where do we stand, where do we go from now?

Biological agents represent a valid therapeutic option in patients with severe and/or relapsing vasculitis. Over the last years, some of these agents have become an established therapy (such as RTX in AAV or IFX for ocular BD), and some appear to hold promise to become so. In addition, there are a number of drugs in the pipeline that may contribute to further improve the prognosis of vasculitis...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 5  issue 2

pages  35- 36

publication date 2019-07-01

{@ msg @}

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023